164 related articles for article (PubMed ID: 719637)
1. Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Dec; 38(12):4522-6. PubMed ID: 719637
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
[TBL] [Abstract][Full Text] [Related]
3. Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.
Howell LE; Kreider JW; Bartlett GL
J Natl Cancer Inst; 1986 Jul; 77(1):187-93. PubMed ID: 3487670
[TBL] [Abstract][Full Text] [Related]
4. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL; Boyer CM; Purnell DM
Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
[TBL] [Abstract][Full Text] [Related]
5. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW; Biro TG
Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
[TBL] [Abstract][Full Text] [Related]
6. Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL
J Natl Cancer Inst; 1985 Jul; 75(1):141-9. PubMed ID: 3859687
[TBL] [Abstract][Full Text] [Related]
7. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
[TBL] [Abstract][Full Text] [Related]
8. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
Boyer CM; Kreider JW; Bartlett GL
Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
[TBL] [Abstract][Full Text] [Related]
9. Effect of prolonged Corynebacterium parvum and cyclophosphamide administration on spontaneously occurring metastases.
Wolmark N; Fisher B
Surg Forum; 1975; 26():136-8. PubMed ID: 1216089
[No Abstract] [Full Text] [Related]
10. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
11. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW
Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
[TBL] [Abstract][Full Text] [Related]
12. Treatment of an intracerebral rat brain tumor with Corynebacterium parvum and radiation.
Douple EB
Natl Cancer Inst Monogr; 1977 Dec; 46():179-84. PubMed ID: 206836
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and necrosis occurring during different stages of primary and metastatic tumor growth of a rat mammary adenocarcinoma.
Matsuda H; Strebel FR; Kaneko T; Stephens LC; Danhauser LL; Jenkins GN; Toyota N; Bull JM
Anticancer Res; 1996; 16(3A):1117-21. PubMed ID: 8702222
[TBL] [Abstract][Full Text] [Related]
14. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
Scott MT; Milas L
Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
[TBL] [Abstract][Full Text] [Related]
15. Correlation of antitumor chemoimmunotherapy with serum inhibition of tumor cell destruction.
Fisher B; Hanlon J; Gebhardt M; Linta J; Saffer E
Cancer Res; 1978 Jan; 38(1):38-41. PubMed ID: 618581
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
Bartlett GL; Kreider JW; Purnell DM
Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
[TBL] [Abstract][Full Text] [Related]
17. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice.
Fisher B; Gunduz N
J Natl Cancer Inst; 1979 Jun; 62(6):1545-51. PubMed ID: 286125
[No Abstract] [Full Text] [Related]
18. Lymphatic metastasis of mammary adenocarcinoma. An experimental study in the rat with a brief review of the literature.
Carr I; Carr J; Dreher B
Invasion Metastasis; 1981; 1(1):34-53. PubMed ID: 6765247
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
[TBL] [Abstract][Full Text] [Related]
20. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
Rabbani SA; Gladu J
Cancer Res; 2002 Apr; 62(8):2390-7. PubMed ID: 11956102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
